Beta-2 Microglobulin
A blood test that measures beta-2 microglobulin levels, which can help assess kidney function and serve as a tumor marker for certain blood cancers.
Select Lab Partner
What this test measures
Beta-2 microglobulin (B2M) is a small protein found on the surface of most cells in the body, particularly immune system cells like white blood cells. When cells break down or are damaged, this protein is released into the bloodstream where it is normally filtered out by healthy kidneys.
This test measures the amount of beta-2 microglobulin in the blood, which can provide valuable information about kidney function and certain types of cancer. In individuals without kidney disease, elevated B2M levels may serve as a marker of altered cell proliferation. While beta-2 microglobulin is a relatively nonspecific marker that can be elevated in many conditions, it is primarily used as a prognostic marker rather than a diagnostic tool.
Who should consider this test
You might consider this test if you are experiencing any of the following:
- Individuals who have been diagnosed with blood cancers such as multiple myeloma, chronic lymphocytic leukemia, or lymphoma may benefit from this test to help monitor disease progression and assess treatment response.
- Those with existing kidney conditions or suspected kidney dysfunction may find this test useful, as abnormal beta-2 microglobulin levels can indicate problems with kidney filtration or tubular function.
- Patients with autoimmune disorders or chronic inflammatory conditions may consider this test, as elevated levels can reflect increased immune system activity.
- Individuals on long-term dialysis treatment may need regular monitoring of beta-2 microglobulin levels to assess the effectiveness of their treatment and watch for complications like dialysis-related amyloidosis.
- People with a family history of blood cancers or other conditions affecting the immune system may consider this test as part of routine health monitoring, though it cannot diagnose these conditions on its own.
What to expect
Preparation
No special preparation is required for this test. No fasting is necessary, and individuals can continue taking their regular medications unless specifically instructed otherwise by their healthcare provider.
Sample Type
The test requires a simple blood draw from a vein, typically in the arm. A small needle is used to collect the blood sample into a test tube or vial.
Collection
At the lab location, a healthcare professional will clean the area, insert a small needle, and collect the blood sample. The entire process typically takes less than five minutes and may involve a slight sting when the needle is inserted.
Turnaround
Results are typically available within 1-3 business days after the sample reaches the laboratory.
Understanding your results
Beta-2 microglobulin levels in blood typically range from 1.5 to 3 mg/L for adults, though this may vary slightly between laboratories. Results should be interpreted in the context of an individual's overall health status and medical history.
| Population | Reference Range | Notes |
|---|---|---|
| Adults | 1.5-3.0 mg/L | Normal range may vary between laboratories |
| Newborns | Up to 5.4 mg/L | Higher levels are considered normal in newborns |
Reference ranges may vary by laboratory and individual factors. Results should be interpreted by a healthcare provider in the context of your overall health.
What does a “Low” result mean?
Low beta-2 microglobulin levels typically indicate decreased disease activity in conditions where B2M is used as a prognostic marker, such as multiple myeloma, lymphoma, or leukemia, or may suggest the absence of such disease processes. In renal tubular disease specifically, serum levels may be low while urine levels are high. However, low levels alone are never used to rule out any particular condition without additional testing and clinical evaluation.
What does a “High” result mean?
Elevated beta-2 microglobulin levels may be associated with blood and bone marrow cancers such as multiple myeloma, chronic lymphocytic leukemia, or certain lymphomas. High levels can also occur in non-cancerous conditions including kidney dysfunction, chronic inflammation, liver disease, some acute viral infections, and various autoimmune disorders. Because elevated B2M can result from such a wide variety of conditions, healthcare providers typically do not use this test alone to diagnose any specific condition.
Privacy & confidentiality
All beta-2 microglobulin test results are completely confidential and protected under HIPAA regulations. Results are not shared with insurance companies, employers, or added to your permanent medical record without your consent, ensuring complete privacy for your health information.
Frequently asked questions
Related tests
Kidney Panel
$49Comprehensive kidney function evaluation when beta-2 microglobulin suggests kidney involvement
View TestComplete Blood Count (CBC)
$29Basic blood cancer screening to complement beta-2 microglobulin tumor marker results
View TestESR + CRP Panel
$49Assesses inflammation levels which may contribute to elevated beta-2 microglobulin
View TestLiver Panel
$39Liver disease can cause elevated beta-2 microglobulin levels
View TestRelated conditions
CPT Code: 82232
This test may not be available in: NY, NJ, RI
This page is for informational purposes only and does not constitute medical advice. Always consult with a healthcare provider regarding any health concerns. LevelPanel does not diagnose, treat, or prescribe.
Select Lab Partner
Not sure if this is the right test? Contact our care team for guidance.